AMGN · 10-Q · 2026Q3 · Full report
Operating Cash Flow Trends
AMGEN INC · 2026-11-04 · Importance 59 · Surprise 48 · Matches filing data
Net cash provided by operating activities increased to $10.432 billion for the nine months ended September 30, 2026, from $8.355 billion in the prior-year period. The increase primarily reflected the final $1.8 billion repatriation tax payment made in the second quarter of 2025 and higher current-year net income after noncash adjustments. The improvement was partly offset by the timing of working-capital items. Operating cash flow remains Amgen’s primary recurring source of funds.
Key facts
- Net cash provided by operating activities was $10.432 billion in the nine months ended September 30, 2026, compared with $8.355 billion in the prior-year period. source
- Amgen's net cash provided by operating activities was $10.432 billion for the nine months ended September 30, 2026, compared with $8.355 billion for the same 2025 period. source
- Operating cash provided increased in the nine months ended September 30, 2026, primarily due to the final $1.8 billion repatriation tax payment in the second quarter of 2025 and higher current-year net income after noncash adjustments, partly offset by working-capital timing. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | positive | realized | +2.2% | Net cash provided by operating activities was $10.432 billion in the nine months ended September 30, 2026, compared with $8.355 billion in… |